{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:38:54Z","timestamp":1790786334484,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Guangdong Province, China","award":["2022A1515012665"],"award-info":[{"award-number":["2022A1515012665"]}]},{"name":"Natural Science Foundation of Guangdong Province, China","award":["2019A1515011083"],"award-info":[{"award-number":["2019A1515011083"]}]},{"name":"Natural Science Foundation of Guangdong Province, China","award":["2021A151501000"],"award-info":[{"award-number":["2021A151501000"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900607"],"award-info":[{"award-number":["81900607"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071563"],"award-info":[{"award-number":["82071563"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000682"],"award-info":[{"award-number":["82000682"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Progressive peritoneal fibrosis is a worldwide public health concern impacting patients undergoing peritoneal dialysis (PD), yet there is no effective treatment. Our previous study revealed that a novel compound, micheliolide (MCL) inhibited peritoneal fibrosis in mice. However, its mechanism remains unclear. Brahma-related gene 1 (BRG1) is a key contributor to organ fibrosis, but its potential function in PD-related peritoneal fibrosis and the relationship between MCL and BRG1 remain unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The effects of MCL on BRG1-induced fibrotic responses and TGF-\u03b21-Smads pathway were examined in a mouse PD model and in vitro peritoneal mesothelial cells. To investigate the targeting mechanism of MCL on BRG1, coimmunoprecipitation, MCL-biotin pulldown, molecular docking and cellular thermal shift assay were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BRG1 was markedly elevated in a mouse PD model and in peritoneal mesothelial cells cultured in TGF-\u03b21 or PD fluid condition. BRG1 overexpression in vitro augmented fibrotic responses and promoted TGF-\u03b21-increased-phosphorylation of Smad2 and Smad3. Meanwhile, knockdown of BRG1 diminished TGF-\u03b21-induced fibrotic responses and blocked TGF-\u03b21-Smad2\/3 pathway. MCL ameliorated BRG1 overexpression-induced peritoneal fibrosis and impeded TGF-\u03b21-Smad2\/3 signaling pathway both in a mouse PD model and in vitro. Mechanically, MCL impeded BRG1 from recognizing and attaching to histone H3 lysine 14 acetylation by binding to the asparagine (N1540) of BRG1, in thus restraining fibrotic responses and TGF-\u03b21-Smad2\/3 signaling pathway. After the mutation of N1540 to alanine (N1540A), MCL was unable to bind to BRG1 and thus, unsuccessful in suppressing BRG1-induced fibrotic responses and TGF-\u03b21-Smad2\/3 signaling pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our research indicates that BRG1 may be a crucial mediator in peritoneal fibrosis and MCL targeting N1540 residue of BRG1 may be a novel therapeutic strategy to combat PD-related peritoneal fibrosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04469-w","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T13:02:10Z","timestamp":1695128530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Brahma-related gene 1 acts as a profibrotic mediator and targeting it by micheliolide ameliorates peritoneal fibrosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Shuting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"4469_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5873","volume":"367","author":"AK Bello","year":"2019","unstructured":"Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ. 2019;367: l5873.","journal-title":"BMJ"},{"issue":"12","key":"4469_CR2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","volume":"18","author":"AK Bello","year":"2022","unstructured":"Bello AK, Okpechi IG, Osman MA, Cho Y, Cullis B, Htay H, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022;18(12):779\u201393.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"4469_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2020.05.032","volume":"77","author":"Y Cho","year":"2021","unstructured":"Cho Y, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Peritoneal dialysis use and practice patterns: an international survey study. Am J Kidney Dis. 2021;77(3):315\u201325.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4469_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40620-018-0485-3","volume":"32","author":"MM Javaid","year":"2019","unstructured":"Javaid MM, Khan BA, Subramanian S. Peritoneal dialysis as initial dialysis modality: a viable option for late-presenting end-stage renal disease. J Nephrol. 2019;32(1):51\u20136.","journal-title":"J Nephrol"},{"issue":"9","key":"4469_CR5","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.3390\/ijms23094831","volume":"23","author":"V Masola","year":"2022","unstructured":"Masola V, Bonomini M, Borrelli S, Di Liberato L, Vecchi L, Onisto M, et al. Fibrosis of peritoneal membrane as target of new therapies in peritoneal dialysis. Int J Mol Sci. 2022;23(9):4831.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4469_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1053\/j.ajkd.2005.08.011","volume":"46","author":"LS Aroeira","year":"2005","unstructured":"Aroeira LS, Aguilera A, Selgas R, Ramirez-Huesca M, Perez-Lozano ML, Cirugeda A, et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis. 2005;46(5):938\u201348.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4469_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","volume":"90","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Bajo MA, del Peso G, Yu X, Selgas R. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int. 2016;90(3):515\u201324.","journal-title":"Kidney Int"},{"issue":"495","key":"4469_CR8","doi-asserted-by":"publisher","first-page":"eaav5341","DOI":"10.1126\/scitranslmed.aav5341","volume":"11","author":"M Si","year":"2019","unstructured":"Si M, Wang Q, Li Y, Lin H, Luo D, Zhao W, et al. Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis. Sci Transl Med. 2019;11(495):eaav5341.","journal-title":"Sci Transl Med"},{"issue":"7","key":"4469_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2009070694","volume":"21","author":"O Devuyst","year":"2010","unstructured":"Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. 2010;21(7):1077\u201385.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4469_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/jcp.28976","volume":"235","author":"N Jiang","year":"2020","unstructured":"Jiang N, Zhang Z, Shao X, Jing R, Wang C, Fang W, et al. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-\u03b21\/Smad3 signaling pathway. J Cell Physiol. 2020;235(1):364\u201379.","journal-title":"J Cell Physiol"},{"issue":"6","key":"4469_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325\u201338.","journal-title":"Nat Rev Nephrol"},{"issue":"6451","key":"4469_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/366170a0","volume":"366","author":"PA Khavari","year":"1993","unstructured":"Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. BRG1 contains a conserved domain of the SWI2\/SNF2 family necessary for normal mitotic growth and transcription. Nature. 1993;366(6451):170\u20134.","journal-title":"Nature"},{"key":"4469_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31780","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Chen Y, Zhang X, Xu Q, Wu Z, Cao X, et al. Brahma-related gene 1 inhibition prevents liver fibrosis and cholangiocarcinoma by attenuating progenitor expansion. Hepatology. 2021. https:\/\/doi.org\/10.1002\/hep.31780.","journal-title":"Hepatology"},{"issue":"7","key":"4469_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41419-020-02744-y","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, Kong X, Zhang Y, Zhang Y, Yu L, Guo J, et al. Dual roles of chromatin remodeling protein BRG1 in angiotensin II-induced endothelial-mesenchymal transition. Cell Death Dis. 2020;11(7):549.","journal-title":"Cell Death Dis"},{"issue":"9","key":"4469_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144652","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang L, Xia H, Smith K, Gilbertsen A, Beisang D, Kuo J, et al. A CD44\/Brg1 nuclear complex confers mesenchymal progenitor cells with enhanced fibrogenicity in idiopathic pulmonary fibrosis. JCI Insight. 2021;6(9): e144652.","journal-title":"JCI Insight."},{"issue":"15","key":"4469_CR16","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1042\/CS20210447","volume":"135","author":"W Gong","year":"2021","unstructured":"Gong W, Luo C, Peng F, Xiao J, Zeng Y, Yin B, et al. Brahma-related gene-1 promotes tubular senescence and renal fibrosis through Wnt\/beta-catenin\/autophagy axis. Clin Sci (Lond). 2021;135(15):1873\u201395.","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"4469_CR17","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.bbadis.2019.06.015","volume":"1865","author":"L Liu","year":"2019","unstructured":"Liu L, Mao L, Wu X, Wu T, Liu W, Yang Y, et al. BRG1 regulates endothelial-derived IL-33 to promote ischemia-reperfusion induced renal injury and fibrosis in mice. BBA-Mol Basis Dis. 2019;1865(9):2551\u201361.","journal-title":"BBA-Mol Basis Dis"},{"issue":"4","key":"4469_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1039\/C9NP00049F","volume":"37","author":"RRA Freund","year":"2020","unstructured":"Freund RRA, Gobrecht P, Fischer D, Arndt HD. Advances in chemistry and bioactivity of parthenolide. Nat Prod Rep. 2020;37(4):541\u201365.","journal-title":"Nat Prod Rep"},{"issue":"17\u201318","key":"4469_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.drudis.2013.05.005","volume":"18","author":"A Ghantous","year":"2013","unstructured":"Ghantous A, Sinjab A, Herceg Z, Darwiche N. Parthenolide: from plant shoots to cancer roots. Drug Discov Today. 2013;18(17\u201318):894\u2013905.","journal-title":"Drug Discov Today"},{"issue":"12","key":"4469_CR20","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41374-022-00834-3","volume":"102","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Feng W, Peng X, Zhu L, Wang Z, Shen H, et al. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-kappaB\/ TGF-beta\/Smad signaling axis. Lab Invest. 2022;102(12):1346\u201354.","journal-title":"Lab Invest"},{"key":"4469_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106064","volume":"78","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Huang Q, Chen Y, Peng X, Wang Y, Li S, et al. Parthenolide, an NF-\u03baB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-\u03b2\/Smad pathway. Int Immunopharmacol. 2020;78: 106064.","journal-title":"Int Immunopharmacol"},{"key":"4469_CR22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/DDDT.S355059","volume":"16","author":"T An","year":"2022","unstructured":"An T, Yin H, Lu Y, Liu F. The emerging potential of parthenolide nanoformulations in tumor therapy. Drug Des Devel Ther. 2022;16:1255\u201372.","journal-title":"Drug Des Devel Ther"},{"issue":"16","key":"4469_CR23","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1021\/jo300888s","volume":"77","author":"J-D Zhai","year":"2012","unstructured":"Zhai J-D, Li D, Long J, Zhang H-L, Lin J-P, Qiu C-J, et al. Biomimetic semisynthesis of arglabin from parthenolide. J Org Chem. 2012;77(16):7103\u20137.","journal-title":"J Org Chem"},{"issue":"20","key":"4469_CR24","doi-asserted-by":"publisher","first-page":"8757","DOI":"10.1021\/jm301064b","volume":"55","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, et al. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem. 2012;55(20):8757\u201369.","journal-title":"J Med Chem"},{"key":"4469_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.canlet.2020.04.003","volume":"483","author":"S Yao","year":"2020","unstructured":"Yao S, Ye J, Yin M, Yu R. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo. Cancer Lett. 2020;483:87\u201397.","journal-title":"Cancer Lett"},{"issue":"5","key":"4469_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41374-019-0301-2","volume":"100","author":"F Peng","year":"2020","unstructured":"Peng F, Li H, Li S, Wang Y, Liu W, Gong W, et al. Micheliolide ameliorates renal fibrosis by suppressing the Mtdh\/BMP\/MAPK pathway (vol 99, pg 1092, 2019). Lab Invest. 2020;100(5):786\u20137.","journal-title":"Lab Invest"},{"issue":"5","key":"4469_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00109-019-01757-1","volume":"97","author":"S Li","year":"2019","unstructured":"Li S, Peng F, Gong W, Wu J, Wang Y, Xu Z, et al. Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy. J Mol Med. 2019;97(5):659\u201374.","journal-title":"J Mol Med"},{"issue":"41","key":"4469_CR28","doi-asserted-by":"publisher","first-page":"15052","DOI":"10.1074\/jbc.RA119.007404","volume":"294","author":"J Wu","year":"2019","unstructured":"Wu J, Huang Q, Li P, Wang Y, Zheng C, Lei X, et al. MicroRNA-145 promotes the epithelial\u2013mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10. J Biol Chem. 2019;294(41):15052\u201367.","journal-title":"J Biol Chem"},{"issue":"9","key":"4469_CR29","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1021\/acs.jmedchem.8b00241","volume":"61","author":"J Li","year":"2018","unstructured":"Li J, Li S, Guo J, Li Q, Long J, Ma C, et al. Natural product micheliolide (MCL) irreversibly activates pyruvate kinase M2 and suppresses leukemia. J Med Chem. 2018;61(9):4155\u201364.","journal-title":"J Med Chem"},{"issue":"14","key":"4469_CR30","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1093\/nar\/gkab617","volume":"49","author":"T Sharma","year":"2021","unstructured":"Sharma T, Robinson DCL, Witwicka H, Dilworth FJ, Imbalzano AN. The Bromodomains of the mammalian SWI\/SNF (mSWI\/SNF) ATPases brahma (BRM) and brahma related gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation. Nucleic Acids Res. 2021;49(14):8060\u201377.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4469_CR31","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1681\/ASN.2010111197","volume":"22","author":"J Loureiro","year":"2011","unstructured":"Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizca\u00edno P, P\u00e9rez-Lozano ML, et al. Blocking TGF-\u03b21 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol. 2011;22(9):1682\u201395.","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"4469_CR32","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1128\/MCB.00546-15","volume":"35","author":"TS Carey","year":"2015","unstructured":"Carey TS, Cao Z, Choi I, Ganguly A, Wilson CA, Paul S, et al. BRG1 governs nanog transcription in early mouse embryos and embryonic stem cells via antagonism of histone H3 lysine 9\/14 acetylation. Mol Cell Biol. 2015;35(24):4158\u201369.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"4469_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101145","volume":"297","author":"P Enr\u00edquez","year":"2021","unstructured":"Enr\u00edquez P, Krajewski K, Strahl BD, Rothbart SB, Dowen RH, Rose RB. Binding specificity and function of the SWI\/SNF subunit SMARCA4 bromodomain interaction with acetylated histone H3K14. J Biol Chem. 2021;297(4): 101145.","journal-title":"J Biol Chem"},{"issue":"4","key":"4469_CR34","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1128\/MCB.01301-07","volume":"28","author":"KW Trotter","year":"2008","unstructured":"Trotter KW, Fan HY, Ivey ML, Kingston RE, Archer TK. The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo. Mol Cell Biol. 2008;28(4):1413\u201326.","journal-title":"Mol Cell Biol"},{"issue":"11","key":"4469_CR35","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.3390\/ijms21114158","volume":"21","author":"RB Wilson","year":"2020","unstructured":"Wilson RB, Archid R. Reprogramming of mesothelial-mesenchymal transition in chronic peritoneal diseases by estrogen receptor modulation and TGF-\u03b21 inhibition. Int J Mol Sci. 2020;21(11):4158.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4469_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1681\/ASN.2013070799","volume":"26","author":"O Busnadiego","year":"2015","unstructured":"Busnadiego O, Loureiro-\u00c1lvarez J, Sandoval P, Lagares D, Dotor J, P\u00e9rez-Lozano ML, et al. A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis. J Am Soc Nephrol. 2015;26(1):173\u201382.","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"4469_CR37","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.3390\/ijerph19148743","volume":"19","author":"Z Niu","year":"2022","unstructured":"Niu Z, Lin J, Hao C, Xu X, Wang C. Glycyrrhizic acid attenuates pulmonary fibrosis of silicosis by inhibiting the interaction between HMGB1 and BRG1 through PI3K\/Akt\/mTOR pathway. Int J Environ Res Public Health. 2022;19(14):8743.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"4469_CR38","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.bbagrm.2019.05.005","volume":"1862","author":"Y Yang","year":"2019","unstructured":"Yang Y, Liu L, Li M, Cheng X, Fang M, Zeng Q, et al. The chromatin remodeling protein BRG1 links ELOVL3 trans-activation to prostate cancer metastasis. Biochim Biophys Acta Gene Regul Mech. 2019;1862(8):834\u201345.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"2","key":"4469_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.yexcr.2018.02.003","volume":"364","author":"H Li","year":"2018","unstructured":"Li H, Lan J, Han C, Guo K, Wang G, Hu J, et al. Brg1 promotes liver fibrosis via activation of hepatic stellate cells. Exp Cell Res. 2018;364(2):191\u20137.","journal-title":"Exp Cell Res"},{"issue":"19","key":"4469_CR40","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1038\/sj.emboj.7601332","volume":"25","author":"S Ross","year":"2006","unstructured":"Ross S, Cheung E, Petrakis TG, Howell M, Kraus WL, Hill CS. Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. Embo j. 2006;25(19):4490\u2013502.","journal-title":"Embo j"},{"issue":"2","key":"4469_CR41","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2353\/ajpath.2010.090447","volume":"176","author":"F Zhu","year":"2010","unstructured":"Zhu F, Li T, Qiu F, Fan J, Zhou Q, Ding X, et al. Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats. Am J Pathol. 2010;176(2):650\u20139.","journal-title":"Am J Pathol"},{"issue":"3","key":"4469_CR42","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1177\/089686080802803s18","volume":"28","author":"Q Liu","year":"2008","unstructured":"Liu Q, Mao H, Nie J, Chen W, Yang Q, Dong X, et al. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int. 2008;28(3):S88-95.","journal-title":"Perit Dial Int"},{"issue":"8","key":"4469_CR43","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1021\/bi0611208","volume":"46","author":"W Shen","year":"2007","unstructured":"Shen W, Xu C, Huang W, Zhang J, Carlson JE, Tu X, et al. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry. 2007;46(8):2100\u201310.","journal-title":"Biochemistry"},{"issue":"2","key":"4469_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1158\/1535-7163.MCT-14-0372","volume":"14","author":"SJ Kwon","year":"2015","unstructured":"Kwon SJ, Lee SK, Na J, Lee SA, Lee HS, Park JH, et al. Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo. Mol Cancer Ther. 2015;14(2):597\u2013607.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"4469_CR45","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.celrep.2018.10.003","volume":"25","author":"T Wu","year":"2018","unstructured":"Wu T, Kamikawa YF, Donohoe ME. Brd4\u2019s bromodomains mediate histone H3 acetylation and chromatin remodeling in pluripotent cells through P300 and Brg1. Cell Rep. 2018;25(7):1756\u201371.","journal-title":"Cell Rep"},{"key":"4469_CR46","doi-asserted-by":"publisher","DOI":"10.1621\/nrs.06004","volume":"6","author":"KW Trotter","year":"2008","unstructured":"Trotter KW, Archer TK. The BRG1 transcriptional coregulator. Nucl Recept Signal. 2008;6: e004.","journal-title":"Nucl Recept Signal"},{"issue":"8","key":"4469_CR47","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/emboj.2010.27","volume":"29","author":"HS Lee","year":"2010","unstructured":"Lee HS, Park JH, Kim SJ, Kwon SJ, Kwon J. A cooperative activation loop among SWI\/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break repair. Embo j. 2010;29(8):1434\u201345.","journal-title":"Embo j"},{"key":"4469_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104506","volume":"150","author":"W Liu","year":"2019","unstructured":"Liu W, Chen X, Wang Y, Chen Y, Chen S, Gong W, et al. Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db\/db mice. Pharmacol Res. 2019;150: 104506.","journal-title":"Pharmacol Res"},{"key":"4469_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3934769","volume":"2020","author":"X Lei","year":"2020","unstructured":"Lei X, Li S, Luo C, Wang Y, Liu Y, Xu Z, et al. Micheliolide attenuates lipopolysaccharide-induced inflammation by modulating the mROS\/NF-kappa B\/NLRP3 axis in renal tubular epithelial cells. Mediators Inflamm. 2020;2020:1.","journal-title":"Mediators Inflamm"},{"key":"4469_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102351","volume":"54","author":"Z Xu","year":"2022","unstructured":"Xu Z, Xu J, Sun S, Lin W, Li Y, Lu Q, et al. Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma. Redox Biol. 2022;54: 102351.","journal-title":"Redox Biol"},{"key":"4469_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.intimp.2018.03.036","volume":"59","author":"J Zhong","year":"2018","unstructured":"Zhong J, Gong W, Chen J, Qing Y, Wu S, Li H, et al. Micheliolide alleviates hepatic steatosis in db\/db mice by inhibiting inflammation and promoting autophagy via PPAR-\u03b3-mediated NF-\u043aB and AMPK\/mTOR signaling. Int Immunopharmacol. 2018;59:197\u2013208.","journal-title":"Int Immunopharmacol"},{"key":"4469_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104973","volume":"111","author":"B Zeng","year":"2021","unstructured":"Zeng B, Cheng Y, Zheng K, Liu S, Shen L, Hu J, et al. Design, synthesis and in vivo anticancer activity of novel parthenolide and micheliolide derivatives as NF-\u03baB and STAT3 inhibitors. Bioorg Chem. 2021;111: 104973.","journal-title":"Bioorg Chem"},{"issue":"182","key":"4469_CR53","first-page":"63903","volume":"28","author":"MY Chang","year":"2022","unstructured":"Chang MY, Wang HH, Chen LH, Gao J, Hung SY, Chiou YY, et al. A mice model of chlorhexidine gluconate-induced peritoneal damage. J Vis Exp. 2022;28(182):63903.","journal-title":"J Vis Exp"},{"key":"4469_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.899140","volume":"13","author":"Y Shi","year":"2022","unstructured":"Shi Y, Li J, Chen H, Hu Y, Tang L, Zhou X, et al. Pharmacologic inhibition of histone deacetylase 6 prevents the progression of chlorhexidine gluconate-induced peritoneal fibrosis by blockade of M2 macrophage polarization. Front Immunol. 2022;13: 899140.","journal-title":"Front Immunol"},{"key":"4469_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.628671","volume":"12","author":"L Ruiqi","year":"2021","unstructured":"Ruiqi L, Ming P, Qihang S, Yangyang L, Junli C, Wei L, et al. Saikosaponin D inhibits peritoneal fibrosis in rats with renal failure by regulation of TGF\u03b21\/ BMP7\/Gremlin1\/Smad pathway. Front Pharmacol. 2021;12: 628671.","journal-title":"Front Pharmacol"},{"issue":"9","key":"4469_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.674786","volume":"14","author":"A Eftekhari","year":"2021","unstructured":"Eftekhari A, Arjmand A, Asheghvatan A, \u0160vajdlenkov\u00e1 H, \u0160au\u0161a O, Huseyn AH, et al. The potential application of magnetic nanoparticles for liver fibrosis theranostics. Front Chem. 2021;14(9): 674786.","journal-title":"Front Chem"},{"issue":"1","key":"4469_CR57","first-page":"5","volume":"8","author":"R Khalilov","year":"2023","unstructured":"Khalilov R. A comprehensive review of advanced nano-biomaterials in regenerative medicine and drug delivery. Adv Biol Earth Sci. 2023;8(1):5\u201318.","journal-title":"Adv Biol Earth Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04469-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04469-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04469-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T09:22:50Z","timestamp":1700472170000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04469-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04469-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal protocol was reviewed and approved by the Animal Experimental Ethics Committee at Southern Medical University (Approval No. LAEC-2020\u2013166).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"639"}}